I. Paul Singh, MD
Show Description +
I. Paul Singh, MD, shares an overview of data from the STAR-I, STAR-II, and STAR-III clinical trials for the MINIject (iSTAR Medical) MIGS device. He explains the patient population and parameters for these studies; outcomes from followup at 36 months including a 35.6% reduction in mean IOP; and how the device has helped patients lower IOP and reduce their medication burden. Dr. Singh also comments on further clinical trials currently underway.
Posted: 8/15/2023
I. Paul Singh, MD
I. Paul Singh, MD, shares an overview of data from the STAR-I, STAR-II, and STAR-III clinical trials for the MINIject (iSTAR Medical) MIGS device. He explains the patient population and parameters for these studies; outcomes from followup at 36 months including a 35.6% reduction in mean IOP; and how the device has helped patients lower IOP and reduce their medication burden. Dr. Singh also comments on further clinical trials currently underway.
Posted: 8/15/2023
About iSTAR Medical
Visit us online: istarmed.com
Follow iSTAR Medical